Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LEGN |
---|---|---|
09:32 ET | 7063 | 43.26 |
09:34 ET | 800 | 43.27 |
09:36 ET | 400 | 43.565 |
09:38 ET | 400 | 43.63 |
09:39 ET | 5973 | 43.97 |
09:41 ET | 7617 | 44.63 |
09:43 ET | 430 | 44.685 |
09:45 ET | 3668 | 44.7 |
09:48 ET | 2353 | 44.83 |
09:50 ET | 1000 | 44.74 |
09:52 ET | 324 | 44.605 |
09:54 ET | 2717 | 44.45 |
09:56 ET | 1277 | 44.435 |
09:57 ET | 1784 | 44.39 |
09:59 ET | 552 | 44.41 |
10:01 ET | 1123 | 44.3 |
10:06 ET | 1553 | 44.155 |
10:10 ET | 782 | 44 |
10:12 ET | 2991 | 43.95 |
10:14 ET | 521 | 43.955 |
10:15 ET | 459 | 44.105 |
10:17 ET | 970 | 44.26 |
10:19 ET | 1651 | 44.22 |
10:21 ET | 718 | 44.28 |
10:24 ET | 1032 | 44.51 |
10:26 ET | 4779 | 44.68 |
10:28 ET | 100 | 44.595 |
10:30 ET | 1475 | 44.6 |
10:32 ET | 1590 | 44.65 |
10:33 ET | 200 | 44.68 |
10:35 ET | 216 | 44.6107 |
10:37 ET | 1600 | 44.66 |
10:39 ET | 1301 | 44.8 |
10:42 ET | 200 | 44.86 |
10:44 ET | 355 | 44.79 |
10:46 ET | 5267 | 44.73 |
10:50 ET | 400 | 44.67 |
10:51 ET | 1008 | 44.71 |
10:53 ET | 9429 | 44.66 |
10:55 ET | 5588 | 44.62 |
10:57 ET | 2458 | 44.64 |
11:00 ET | 804 | 44.8 |
11:02 ET | 843 | 44.6875 |
11:04 ET | 17176 | 44.575 |
11:06 ET | 668 | 44.61 |
11:08 ET | 2458 | 44.7 |
11:11 ET | 1400 | 44.75 |
11:13 ET | 6463 | 44.755 |
11:15 ET | 1800 | 44.7 |
11:18 ET | 5767 | 44.81 |
11:20 ET | 800 | 44.81 |
11:22 ET | 1600 | 44.87 |
11:24 ET | 1000 | 44.95 |
11:26 ET | 3339 | 44.98 |
11:27 ET | 800 | 44.92 |
11:29 ET | 3921 | 44.91 |
11:31 ET | 1650 | 44.915 |
11:33 ET | 45375 | 44.97 |
11:36 ET | 4802 | 44.595 |
11:38 ET | 500 | 44.565 |
11:40 ET | 3738 | 44.77 |
11:42 ET | 200 | 44.75 |
11:44 ET | 1270 | 44.71 |
11:45 ET | 300 | 44.595 |
11:47 ET | 619 | 44.62 |
11:49 ET | 546 | 44.69 |
11:51 ET | 500 | 44.66 |
11:54 ET | 10515 | 44.46 |
11:56 ET | 1736 | 44.35 |
11:58 ET | 2245 | 44.41 |
12:00 ET | 200 | 44.38 |
12:02 ET | 505 | 44.26 |
12:03 ET | 1665 | 44.3 |
12:05 ET | 9072 | 44.205 |
12:07 ET | 1874 | 44.25 |
12:09 ET | 1283 | 44.3 |
12:12 ET | 9443 | 44.48 |
12:14 ET | 3169 | 44.47 |
12:16 ET | 6723 | 44.5 |
12:18 ET | 1267 | 44.5 |
12:20 ET | 746 | 44.5 |
12:21 ET | 22667 | 44.52 |
12:23 ET | 12423 | 44.47 |
12:25 ET | 2155 | 44.62 |
12:30 ET | 973 | 44.79 |
12:32 ET | 623 | 44.6025 |
12:34 ET | 1700 | 44.54 |
12:36 ET | 235 | 44.555 |
12:38 ET | 1056 | 44.49 |
12:39 ET | 1042 | 44.55 |
12:41 ET | 443 | 44.5 |
12:43 ET | 3800 | 44.53 |
12:45 ET | 1600 | 44.47 |
12:48 ET | 4700 | 44.57 |
12:50 ET | 2117 | 44.485 |
12:52 ET | 21947 | 44.315 |
12:54 ET | 2444 | 44.355 |
12:56 ET | 1885 | 44.27 |
12:57 ET | 1200 | 44.125 |
12:59 ET | 2458 | 44.12 |
01:01 ET | 9018 | 43.91 |
01:03 ET | 34486 | 43.62 |
01:06 ET | 1251 | 43.51 |
01:08 ET | 13570 | 43.54 |
01:10 ET | 1070 | 43.49 |
01:12 ET | 2448 | 43.54 |
01:14 ET | 9212 | 43.54 |
01:15 ET | 400 | 43.53 |
01:17 ET | 40046 | 43.27 |
01:19 ET | 500 | 43.25 |
01:21 ET | 42039 | 42.79 |
01:24 ET | 45760 | 42.365 |
01:26 ET | 34199 | 41.98 |
01:28 ET | 104473 | 42.35 |
01:30 ET | 1951 | 42.1 |
01:32 ET | 413 | 42.03 |
01:33 ET | 3149 | 42.225 |
01:35 ET | 3737 | 42.35 |
01:37 ET | 6011 | 42.435 |
01:39 ET | 25200 | 42.21 |
01:42 ET | 7721 | 42.28 |
01:44 ET | 7008 | 42.28 |
01:46 ET | 53391 | 41.99 |
01:48 ET | 3747 | 42.05 |
01:50 ET | 3157 | 41.935 |
01:51 ET | 4782 | 42.07 |
01:53 ET | 1822 | 41.99 |
01:55 ET | 1881 | 41.995 |
01:57 ET | 300 | 41.975 |
02:00 ET | 2960 | 41.9375 |
02:02 ET | 1400 | 42 |
02:04 ET | 48883 | 41.92 |
02:06 ET | 32248 | 42 |
02:08 ET | 24360 | 42.2299 |
02:09 ET | 900 | 42.15 |
02:11 ET | 4265 | 41.99 |
02:13 ET | 600 | 41.96 |
02:15 ET | 2031 | 41.98 |
02:18 ET | 3003 | 42.04 |
02:20 ET | 3072 | 41.965 |
02:22 ET | 6382 | 41.95 |
02:24 ET | 2034 | 41.995 |
02:26 ET | 12379 | 41.735 |
02:27 ET | 28106 | 41.69 |
02:29 ET | 2253 | 41.505 |
02:31 ET | 5264 | 41.68 |
02:33 ET | 416 | 41.74 |
02:36 ET | 3547 | 41.51 |
02:38 ET | 42186 | 41.32 |
02:40 ET | 4702 | 41.335 |
02:42 ET | 15585 | 40.945 |
02:44 ET | 38462 | 40.7 |
02:45 ET | 62068 | 40.835 |
02:47 ET | 6066 | 40.47 |
02:49 ET | 18399 | 40.18 |
02:51 ET | 9172 | 40.365 |
02:54 ET | 2400 | 40.22 |
02:56 ET | 40335 | 40.54 |
02:58 ET | 5570 | 40.49 |
03:00 ET | 63902 | 40.465 |
03:02 ET | 18253 | 40.72 |
03:03 ET | 13417 | 40.86 |
03:05 ET | 12874 | 40.76 |
03:07 ET | 6778 | 40.895 |
03:09 ET | 12705 | 40.73 |
03:12 ET | 6525 | 40.875 |
03:14 ET | 7880 | 40.855 |
03:16 ET | 10662 | 40.67 |
03:18 ET | 12732 | 40.64 |
03:20 ET | 5276 | 40.545 |
03:21 ET | 5335 | 40.55 |
03:23 ET | 21744 | 40.65 |
03:25 ET | 72230 | 40.63 |
03:27 ET | 12038 | 40.425 |
03:30 ET | 18465 | 40.55 |
03:32 ET | 9158 | 40.495 |
03:34 ET | 13500 | 40.445 |
03:36 ET | 12982 | 40.47 |
03:38 ET | 11955 | 40.345 |
03:39 ET | 14596 | 40.42 |
03:41 ET | 30943 | 40.565 |
03:43 ET | 9967 | 40.455 |
03:45 ET | 30289 | 40.405 |
03:48 ET | 36484 | 40.385 |
03:50 ET | 25159 | 40.47 |
03:52 ET | 41027 | 40.34 |
03:54 ET | 19069 | 40.4 |
03:56 ET | 57505 | 40.065 |
03:57 ET | 71079 | 39.95 |
03:59 ET | 459913 | 40.01 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Legend Biotech Corp | 7.3B | -15.4x | --- |
Blueprint Medicines Corp | 6.6B | -21.9x | --- |
Intra-Cellular Therapies Inc | 7.1B | -58.3x | --- |
Ascendis Pharma A/S | 7.9B | -14.0x | --- |
Insmed Inc | 9.0B | -10.5x | --- |
Cerevel Therapeutics Holdings Inc | 7.4B | -15.0x | --- |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.3B |
---|---|
Revenue (TTM) | $342.8M |
Shares Outstanding | 182.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.09 |
EPS | $-2.60 |
Book Value | $6.88 |
P/E Ratio | -15.4x |
Price/Sales (TTM) | 21.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -157.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.